251 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 10:27
205 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 09:58
219 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 09:28
232 0 Fei Yifei 2016-8-22 publish Last reply on 2016-8-22 09:23
309 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 12:03
240 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 11:41
267 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 11:14
258 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 10:42
329 0 Fei Yifei 2016-8-20 publish Last reply on 2016-8-20 21:47
243 0 Xinjiang Wanyintong 2016-8-20 publish Last reply on 2016-8-20 20:23
293 0 Xinjiang Wanyintong 2016-8-20 publish Last reply on 2016-8-20 19:57
309 0 Wuhan Medical 2016-8-20 publish Last reply on 2016-8-20 15:40
215 0 special characteristics 2016-8-20 publish Last reply on 2016-8-20 09:32
209 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 16:36
237 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 14:56
248 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 11:52
234 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 10:29
253 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 09:23
295 0 special characteristics 2016-8-19 publish Last reply on 2016-8-19 09:03
234 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 19:22
202 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 17:20
245 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 16:14
276 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 13:00
244 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 11:19
254 0 Li Wanxi 2016-8-18 publish Last reply on 2016-8-18 11:17
Point rules of this version Post Rebroadcast to the audience